Pharmaceutical Industry Shifts Toward Direct-to-Consumer (DTC) Drug Delivery Model

Strategic Insights -

President Trump's May 12 Executive Order aimed at lowering prescription drug prices has sent the pharmaceutical industry scrambling to explore alternative delivery models, with many manufacturers embracing the direct-to-consumer (DTC) program. This shift is not new, as manufacturers had already identified the DTC model as a potential solution to make their most expensive medications accessible to patients. However, the Executive Order has accelerated this move, with over 60% of the top 10 highest-grossing pharmaceutical manufacturers implementing or preparing to implement DTC programs.

The DTC model involves bypassing traditional intermediaries, such as insurers and pharmacy benefit managers (PBMs), to sell medications directly to patients through telehealth platforms and other DTC providers. Eli Lilly, Novo Nordisk, Pfizer, and Bristol Myers Squibb are among the manufacturers leading this charge. For instance, Eli Lilly and Novo Nordisk have partnered with telehealth platforms to provide their respective obesity and diabetes treatments at a discounted price directly to consumers without insurance coverage. The platforms integrate with the manufacturers' self-pay pharmacies and offer additional services, such as patient education, refill reminders, and disease management support.

Key Takeaways:

  • Over 60% of the top 10 highest-grossing pharmaceutical manufacturers have implemented or are preparing to implement DTC programs.
  • Eli Lilly and Novo Nordisk have partnered with telehealth platforms to offer discounted medications for obesity and diabetes treatments directly to consumers.
  • Pfizer and Bristol Myers Squibb have launched a DTC online program, Eliquis 360 Support, which allows uninsured or underinsured patients to buy their blood thinner Eliquis online at a discounted price.
  • Roche has begun discussions with the HHS Secretary to explore a DTC model for its obesity products.
  • The DTC model integrates telehealth platforms, increasing access to care and eliminating intermediaries like PBMs, but also raises concerns about patient and provider steering.
  • Lawmakers have raised concerns about the potential for DTC partnerships to drive patients toward unnecessary medications and increase spending for federal health care programs.
  • The End Prescription Drug Ads Now Act, sponsored by Senators Bernie Sanders and Angus King, aims to ban manufacturers from advertising their prescription drugs and biologics through television, radio, print, digital platforms, and social media.
  • BlinkRx has unveiled an initiative to help manufacturers set up direct distribution channels for DTC sales, while the Trump administration has met with retailers to explore ways to facilitate distribution and delivery of drugs directly from manufacturers to patients.

Statistics:

  • 60% of the top 10 highest-grossing pharmaceutical manufacturers have implemented or are preparing to implement DTC programs.
  • $346 per month is the discounted price of Eliquis through the Eliquis 360 Support program, a 43% reduction from its current list price of $606 per month.
  • 90% of patients who are currently prescribed Eliquis access it through Medicare or commercial insurance.
  • 21 days is the timeframe for manufacturers to set up direct distribution channels through BlinkRx's Operation Access Now program.
  • 231 is the Medicare's negotiated maximum fair price (MFP) for Eliquis, set to take effect next year.

Sources:

  • "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" Executive Order, May 12.
  • Eli Lilly and Novo Nordisk press releases on their DTC partnerships.
  • Pfizer and Bristol Myers Squibb press release on their Eliquis 360 Support program.
  • Roche's investor presentation on its DTC plans.
  • BlinkRx's Operation Access Now program.
  • Senators Bernie Sanders, Angus King, Dick Durbin, Elizabeth Warren, Peter Welch, and Roger Marshall's statements and press releases on the End Prescription Drug Ads Now Act.
  • Mondaq article on the DTC drug delivery model.